Fei Su

646 total citations
27 papers, 330 citations indexed

About

Fei Su is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Fei Su has authored 27 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Fei Su's work include Advanced Breast Cancer Therapies (12 papers), Cancer Genomics and Diagnostics (7 papers) and Lung Cancer Research Studies (5 papers). Fei Su is often cited by papers focused on Advanced Breast Cancer Therapies (12 papers), Cancer Genomics and Diagnostics (7 papers) and Lung Cancer Research Studies (5 papers). Fei Su collaborates with scholars based in China, United States and Switzerland. Fei Su's co-authors include Nadia Solovieff, Naveen Babbar, Tetiana Taran, Anwesha Chaudhury, Olga Martínez‐Sáez, Aleix Prat, Agnes Lteif, Eduardo Martínez de Dueñas, Fara Brasó‐Maristany and Laia Paré and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Fei Su

27 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Su China 11 190 190 145 48 42 27 330
Ivana Mikulić Austria 2 93 0.5× 119 0.6× 16 0.1× 17 0.4× 8 0.2× 4 293
Iwona Osińska Poland 7 52 0.3× 106 0.6× 31 0.2× 5 0.1× 9 0.2× 12 303
Xuan Dung Ho Vietnam 8 84 0.4× 56 0.3× 109 0.8× 5 0.1× 6 0.1× 15 294
Ilona Spyra Germany 10 45 0.2× 95 0.5× 35 0.2× 13 0.3× 5 0.1× 13 327
Amy E. Schade United States 7 31 0.2× 117 0.6× 44 0.3× 19 0.4× 8 0.2× 10 337
Stine Kiær Larsen Denmark 8 28 0.1× 235 1.2× 34 0.2× 15 0.3× 4 0.1× 14 421
Alain Zasadzinski France 3 24 0.1× 23 0.1× 64 0.4× 19 0.4× 21 0.5× 4 231
Oliver Sampson United Kingdom 5 28 0.1× 56 0.3× 35 0.2× 7 0.1× 11 0.3× 9 209
Shuyuan Xian China 10 35 0.2× 29 0.2× 42 0.3× 9 0.2× 9 0.2× 44 232
Antonio Palma United States 7 18 0.1× 56 0.3× 73 0.5× 8 0.2× 7 0.2× 21 219

Countries citing papers authored by Fei Su

Since Specialization
Citations

This map shows the geographic impact of Fei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Su more than expected).

Fields of papers citing papers by Fei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Su. The network helps show where Fei Su may publish in the future.

Co-authorship network of co-authors of Fei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Su. A scholar is included among the top collaborators of Fei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Su. Fei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaofeng, Min Chen, Yin Shen, et al.. (2024). A longitudinal electrophysiological and behavior dataset for PD rat in response to deep brain stimulation. Scientific Data. 11(1). 500–500. 1 indexed citations
2.
3.
Fairchild, Lauren, Jincheng Wu, Nadia Solovieff, et al.. (2023). Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing. Science Translational Medicine. 15(689). eabm8729–eabm8729. 23 indexed citations
4.
Chiu, Joanne, Fei Su, Norikazu Masuda, et al.. (2023). Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial. BMC Medicine. 21(1). 306–306. 13 indexed citations
5.
Prat, Aleix, Nadia Solovieff, Fabrice André, et al.. (2023). Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2− Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7. Clinical Cancer Research. 30(4). 793–802. 8 indexed citations
6.
Su, Fei, et al.. (2023). Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study. BMC Gastroenterology. 23(1). 440–440. 5 indexed citations
7.
8.
Su, Fei, et al.. (2022). Development of semicircular canal occlusion. Frontiers in Neuroscience. 16. 977323–977323. 3 indexed citations
9.
Prat, Aleix, Anwesha Chaudhury, Nadia Solovieff, et al.. (2021). Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies. Journal of Clinical Oncology. 39(13). 1458–1467. 90 indexed citations
10.
11.
Yap, Yoon Sim, Joanne Chiu, Yoshinori Ito, et al.. (2020). Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer. Cancer Science. 111(9). 3313–3326. 10 indexed citations
12.
13.
Fu, Hanjiang, Yong Xue, Fei Su, et al.. (2020). Plasma Proteins as Biomarkers of Mortality After Total Body Irradiation in Mice. Dose-Response. 18(2). 3794410734–3794410734. 2 indexed citations
14.
André, Fabrice, Fei Su, Nadia Solovieff, et al.. (2020). Pooled ctDNA analysis of the MONALEESA (ML) phase III advanced breast cancer (ABC) trials.. Journal of Clinical Oncology. 38(15_suppl). 1009–1009. 35 indexed citations
15.
Zhang, Zhendong, et al.. (2019). Field evaluation of Mosq-ovitrap, Ovitrap and a CO 2 -light trap for Aedes albopictus sampling in Shanghai, China. PeerJ. 7. e8031–e8031. 10 indexed citations
16.
Lu, Yen‐Shen, Sara A. Hurvitz, Fei Su, et al.. (2019). In-depth gene expression analysis of premenopausal patients with HR+/HER2− advanced breast cancer (ABC) treated with ribociclib-containing therapy in the Phase III MONALEESA-7 trial.. Journal of Clinical Oncology. 37(15_suppl). 1018–1018. 5 indexed citations
17.
Wang, Fei, et al.. (2018). Aedes albopictus production in urban stormwater catch basins and manhole chambers of downtown Shanghai, China. PLoS ONE. 13(8). e0201607–e0201607. 16 indexed citations
18.
Campone, Mario, Norbert Marschner, Cristian Villanueva, et al.. (2017). First-line ribociclib + letrozole in HR+, HER2– ABC: Efficacy by baseline tumor markers. Annals of Oncology. 28. i7–i7. 2 indexed citations
19.
Xiong, Chenglong, et al.. (2016). Structure, Spatial and Temporal Distribution of the Culex pipiens Complex in Shanghai, China. International Journal of Environmental Research and Public Health. 13(11). 1150–1150. 11 indexed citations
20.
Zou, Yihuai, Jianjun Zhao, Shuquan Zhang, et al.. (2012). Efficacy of Chuanxiong Ding Tong Herbal Formula Granule in the Treatment and Prophylactic of Migraine Patients: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2012. 1–9. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivana Mikulić Breakdown of academic impact, for papers by Iwona Osińska Breakdown of academic impact, for papers by Xuan Dung Ho Breakdown of academic impact, for papers by Ilona Spyra Breakdown of academic impact, for papers by Amy E. Schade Breakdown of academic impact, for papers by Stine Kiær Larsen Breakdown of academic impact, for papers by Alain Zasadzinski Breakdown of academic impact, for papers by Oliver Sampson Breakdown of academic impact, for papers by Shuyuan Xian Breakdown of academic impact, for papers by Antonio Palma
Rankless by CCL
2026